| D68 |
Other coagulation defects |
| D68.0 |
Von Willebrand disease |
| D68.01 |
Von Willebrand disease, type 1 |
| D68.02 |
Von Willebrand disease, type 2 |
| D68.020 |
Von Willebrand disease, type 2A |
| D68.021 |
Von Willebrand disease, type 2B |
| D68.022 |
Von Willebrand disease, type 2M |
| D68.023 |
Von Willebrand disease, type 2N |
| D68.029 |
Von Willebrand disease, type 2, unspecified |
| D68.03 |
Von Willebrand disease, type 3 |
| D68.04 |
Acquired von Willebrand disease |
| D68.09 |
Other von Willebrand disease |
| D68.1 |
Hereditary factor XI deficiency |
| D68.2 |
Hereditary deficiency of other clotting factors |
| D68.3 |
Hemorrhagic disorder due to circulating anticoagulants |
| D68.31 |
Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
| D68.311 |
Acquired hemophilia |
| D68.312 |
Antiphospholipid antibody with hemorrhagic disorder |
| D68.318 |
Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors |
| D68.32 |
Hemorrhagic disorder due to extrinsic circulating anticoagulants |
| D68.4 |
Acquired coagulation factor deficiency |
| D68.5 |
Primary thrombophilia |
| D68.51 |
Activated protein C resistance |
| D68.52 |
Prothrombin gene mutation |
| D68.59 |
Other primary thrombophilia |
| D68.6 |
Other thrombophilia |
| D68.61 |
Antiphospholipid syndrome |
| D68.62 |
Lupus anticoagulant syndrome |
| D68.69 |
Other thrombophilia |
| D68.8 |
Other specified coagulation defects |
| D68.9 |
Coagulation defect, unspecified |